CME Group Inc. $CME Shares Sold by Nwam LLC

Nwam LLC lowered its position in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 63.8% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 1,107 shares of the financial services provider’s stock after selling 1,949 shares during the period. Nwam LLC’s holdings in CME Group were worth $244,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of the company. Whipplewood Advisors LLC boosted its stake in CME Group by 2,075.0% during the 1st quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 83 shares during the period. Elkhorn Partners Limited Partnership acquired a new stake in shares of CME Group in the fourth quarter valued at approximately $27,000. Hilton Head Capital Partners LLC bought a new stake in shares of CME Group during the fourth quarter valued at approximately $28,000. Mowery & Schoenfeld Wealth Management LLC bought a new stake in shares of CME Group during the second quarter valued at approximately $28,000. Finally, Legacy Wealth Managment LLC ID boosted its position in shares of CME Group by 191.9% during the fourth quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after buying an additional 71 shares during the period. 87.75% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other CME Group news, Director William Shepard purchased 325 shares of the business’s stock in a transaction on Thursday, June 25th. The stock was bought at an average cost of $230.57 per share, with a total value of $74,935.25. Following the acquisition, the director owned 260,442 shares of the company’s stock, valued at $60,050,111.94. The trade was a 0.12% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently issued reports on CME. UBS Group decreased their price objective on CME Group from $310.00 to $260.00 and set a “buy” rating for the company in a report on Monday, July 6th. Weiss Ratings cut CME Group from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. Deutsche Bank Aktiengesellschaft lowered CME Group from a “buy” rating to a “hold” rating and lowered their price target for the company from $286.00 to $270.00 in a report on Wednesday, August 19th. Erste Group Bank downgraded shares of CME Group from a “buy” rating to a “hold” rating in a report on Friday, June 5th. Finally, TD Cowen reiterated a “buy” rating and issued a $292.00 target price on shares of CME Group in a research report on Thursday. Nine equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $289.75.

Check Out Our Latest Report on CME Group

CME Group Stock Performance

Shares of NASDAQ CME opened at $281.29 on Friday. The stock has a fifty day moving average price of $258.76 and a two-hundred day moving average price of $278.38. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The firm has a market cap of $101.15 billion, a P/E ratio of 23.86, a PEG ratio of 3.33 and a beta of 0.24. CME Group Inc. has a 1 year low of $218.31 and a 1 year high of $329.16.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. The company had revenue of $1.71 billion for the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company’s quarterly revenue was up .8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.96 EPS. Research analysts forecast that CME Group Inc. will post 12.27 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be given a $1.30 dividend. The ex-dividend date is Wednesday, September 9th. This represents a $5.20 annualized dividend and a yield of 1.8%. CME Group’s payout ratio is 44.11%.

CME Group Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.